Bamzireotide navoxetan

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C72H106N16O20S2
Molecular Weight	1579.837
Optical Activity	UNSPECIFIED
Defined Stereocenters	10 / 10
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CCOCCOCCNC(=O)CN3CCN(CC(O)=O)CCN(CC(N)=O)CCN(CC(O)=O)CC3)C(=O)N[C@@H](CC4=CC=C(O)C=C4)C(=O)N[C@H](CC5=CNC6=C5C=CC=C6)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1

InChI

InChIKey=FWJUFDDPKXRKHG-AYPXNPRASA-N

InChI=1S/C72H106N16O20S2/c1-45(90)57(42-89)81-71(105)59-44-110-109-43-58(70(104)79-55(35-48-15-17-50(92)18-16-48)68(102)80-56(36-49-37-76-52-13-7-6-12-51(49)52)69(103)78-53(14-8-9-20-73)66(100)84-65(46(2)91)72(106)83-59)82-67(101)54(34-47-10-4-3-5-11-47)77-61(94)19-30-107-32-33-108-31-21-75-62(95)39-86-24-28-87(40-63(96)97)26-22-85(38-60(74)93)23-27-88(29-25-86)41-64(98)99/h3-7,10-13,15-18,37,45-46,53-59,65,76,89-92H,8-9,14,19-36,38-44,73H2,1-2H3,(H2,74,93)(H,75,95)(H,77,94)(H,78,103)(H,79,104)(H,80,102)(H,81,105)(H,82,101)(H,83,106)(H,84,100)(H,96,97)(H,98,99)/t45-,46-,53+,54-,55+,56-,57-,58+,59+,65+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C72H106N16O20S2
Molecular Weight	1579.837
Charge	0
Count

Stereochemistry	EPIMERIC
Additional Stereochemistry	No
Defined Stereocenters	10 / 10
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 16:45:37 GMT 2025` Edited by `admin` on `Wed Apr 02 16:45:37 GMT 2025`
Record UNII	YZ3YX5R472
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

L-Cysteinamide, N-[3-[2-[2-[[2-[7-(2-amino-2-oxoethyl)-4,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]amino]ethoxy]ethoxy]-1-oxopropyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxym

Preferred Name

English

Bamzireotide navoxetan

Common Name

English

Code System Code Type Description

CAS

2641216-35-3

Created by admin on Wed Apr 02 16:45:37 GMT 2025 , Edited by admin on Wed Apr 02 16:45:37 GMT 2025

PRIMARY

FDA UNII

YZ3YX5R472

Created by admin on Wed Apr 02 16:45:37 GMT 2025 , Edited by admin on Wed Apr 02 16:45:37 GMT 2025

PRIMARY

Related Record Type Details


					D2A42X3LCS

Lead Bamzireotide Navoxetan Pb-212

LABELED -> NON-LABELED

Amount: